Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Search
Subscribe
Home
Contact Us
Subscription Services
Promote Your Event
e-Edition
News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Place an Ad
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Annovis Bio Inc
(NY:
ANVS
)
8.895
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
8.895
Bid (Size)
3.560 (2)
Ask (Size)
13.98 (1)
Prev. Close
8.895
Today's Range
8.895 - 8.895
52wk Range
8.720 - 23.89
Shares Outstanding
9,012,273
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Annovis Bio Announces Second Quarter 2023 Financial Results and Provides Corporate Update
August 15, 2023
From
Annovis Bio, Inc.
Via
Business Wire
3 Biotech Stocks to Buy Before Drug Trials End
July 28, 2023
Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.
Via
InvestorPlace
Performance
YTD
-31.52%
-31.52%
1 Month
-24.43%
-24.43%
3 Month
-36.46%
-36.46%
6 Month
-25.56%
-25.56%
1 Year
-35.40%
-35.40%
More News
Read More
Continued Positive Performance of Novel Drug Development by Annovis Bio Presented at 2023 Alzheimer's Association International Conference
July 18, 2023
From
Annovis Bio, Inc.
Via
Business Wire
Recap: Annovis Bio Q1 Earnings
May 11, 2023
Via
Benzinga
Annovis Bio Announces the Filing of a Groundbreaking Patent
June 27, 2023
From
Annovis Bio, Inc.
Via
Business Wire
Annovis Bio Receives Excellent Safety Rating and Positive Recommendation to Continue Phase III Trial of Buntanetap for Parkinson’s Disease Patients from the Independent Data and Safety Monitoring Board (DSMB)
June 20, 2023
From
Annovis Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
Tesla, NIO And Other Big Stocks Moving Lower On Monday
April 03, 2023
Via
Benzinga
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 03, 2023
Via
Benzinga
Quarterly Gain Still Eludes Dow Despite Triple-Digit Lead
March 31, 2023
Via
Talk Markets
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 31, 2023
Via
Benzinga
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday
March 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 27, 2023
Via
Benzinga
Dear PSNY Stock Fans, Mark Your Calendars for Oct. 12
October 06, 2022
Via
InvestorPlace
Why Is Annovis Bio (ANVS) Stock Up 12% Today?
October 06, 2022
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 06, 2022
Via
Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Via
Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Via
Benzinga
Stocks Deepen Losses As Treasury Yields Soar
September 20, 2022
Via
Talk Markets
S&P 500 Down 0.6%; Crude Oil Falls Sharply
September 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 15, 2022
Via
Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
September 12, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.